Harvard Bioscience, Inc. (FRA:HBI)
0.5550
-0.0200 (-3.48%)
Last updated: Jan 8, 2026, 8:01 AM CET
Harvard Bioscience Market Cap
Harvard Bioscience has a market cap or net worth of €24.16 million as of January 9, 2026. Its market cap has decreased by -72.58% in one year.
Market Cap
24.16M
Enterprise Value
55.08M
Revenue
74.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.56
Market Cap Chart
Since December 7, 2000, Harvard Bioscience's market cap has decreased from 218.76M to 24.16M, a decrease of -88.96%. That is a compound annual growth rate of -8.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 24.16M | -4.86% |
| Dec 31, 2025 | 25.39M | -71.43% |
| Dec 31, 2024 | 88.89M | -56.98% |
| Dec 29, 2023 | 206.62M | 91.36% |
| Dec 30, 2022 | 107.97M | -57.32% |
| Dec 31, 2021 | 252.99M | 85.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |